You are here

Heart Failure


Individuals with higher levels of cardiac troponin in their blood are at greater risk for developing heart failure for the first time, according to a meta-analysis published in JACC: Heart Failure.

The prevalence of left ventricular systolic dysfunction (LVSD) has declined over the last 30 years, and heart failure patients are increasingly demonstrating preserved ejection fraction versus reduced ejection fraction, according to a study published in JACC: Cardiovascular Imaging.

Previously sedentary, middle-aged adults who devote themselves to regular aerobic exercise for two years can increase their maximal oxygen uptake and decrease cardiac stiffness, according to new research published in Circulation.

Women who undergo hysterectomies—especially those under 35 years old—are nearly five times more likely to develop congestive heart failure and are at increased risk for a slew of other coronary complications, according to a study of more than 2,000 Minnesota women.

More than 10 percent of heart transplant recipients developed cancer between one and five years post-transplantation—most commonly skin cancer—according to a study published in the Journal of the American College of Cardiology.


Recent Headlines

Optimal drug dosing after heart failure extends patients’ careers

Patients who receive target or near-target doses of evidence-based medicine (EBM) are more likely to continue working after a heart failure hospitalization, according to a study of Danish individuals published Dec. 6 in JACC: Heart Failure.

Heart cell damage during non-cardiac surgery can be fatal, but often unnoticed

Damage inflicted during non-cardiac surgery can reach heart cells and significantly raise a patient’s risk of mortality for up to one year after the procedure, according to research published this week in the American Heart Association journal Circulation.

Engineers develop living heart muscle large enough to cover area damaged by MI

Biomedical engineers at Duke University have created a fully functioning heart muscle from pluripotent stem cells that is large enough to patch over damaged areas in human heart attack patients.

Heart failure-related hospitalizations, mortalities see downward trend

Heart failure-related hospitalizations and in-hospital mortalities have decreased significantly since the turn of the millennium, the American Heart Association has reported, despite a general increase in the burden of heart failure (HF) comorbidities.

Researchers detail trends of increasing heart failure across UK

The number of new people diagnosed with heart failure each year in the United Kingdom is now similar to that of the most four common types of cancer combined, according to the most comprehensive review of heart failure statistics in the U.K. to date, published online Nov. 21 in The Lancet.

30% of heart patients still taking prescribed statins 3 years later

While 71 percent of heart patients are prescribed statins after hospitalization for heart disease, cerebrovascular disease and peripheral artery disease, just 37.4 percent retain that medication regimen a year later, researchers in Salt Lake City reported this week.

Novel discovery suggests MRIs after cardiac arrest could predict patient outcomes

Patients who suffer brain damage after cardiac arrest could benefit from magnetic resonance (MR) imaging following their stabilization—a measure that has been shown to predict clinical outcomes through mapping brain activity, according to new research published in the American journal Radiology.

AHA: Blacks living shorter lives due to CVD, stroke

African Americans are dying an average of 3.4 years before white Americans, a significant gap that’s attributable to more prevalent cardiovascular disease (CVD) and risk factors in the black population, the American Heart Association (AHA) reported in a scientific statement published Monday in Circulation.

Children awaiting heart transplant survive longer with VADs than ECMO

Ventricular assist devices (VADs) foster improved survival for children awaiting heart transplantation when compared to the current standard of extracorporeal membrane oxygenation (ECMO), according to a new study in the Journal of the American College of Cardiology.

Researchers call for more patient-centered designs, outcomes in cardiovascular trials

Cardiovascular research has traditionally focused on hard clinical endpoints such as markers of disease progression, adverse events and death. But now researchers are calling for more studies that incorporate the viewpoints of patients and caregivers, both in trial design and execution and in measuring outcomes like quality of life, time off work, out-of-pocket expense and caregiver burden.